CN112159475A
|
|
Siglec-15 monoclonal antibody and application thereof
|
CN112142854A
|
|
Immune regulation specific chimeric antigen receptor cell and preparation method and application thereof
|
CN111978412A
|
|
Armed targeting TGF-beta specific chimeric antigen receptor cell and preparation method and application thereof
|
CN111607006A
|
|
Specific chimeric antigen receptor cell armed with CXCR 2-targeting ligand and preparation method and application thereof
|
CN111675765A
|
|
Armed chimeric antigen receptor cell of targeted coronavirus SPIKE, preparation method and application
|
WO2019061012A1
|
|
Preparation of chimeric antigen receptor t-cell specifically targeting cd47 and application thereof
|
WO2018165913A1
|
|
Specific chimeric antigen receptor targeting nkg2dl and car-t cell thereof and use thereof
|
WO2018040537A1
|
|
Preparation method for cldn18.2 specific chimeric antigen receptor t-cell with human pd-1 gene knockout and use thereof
|
CN106480097A
|
|
Knocking out that people PD 1 is gene constructed using CRISPR/Cas9 technology can the method for targeting MSLN novel C AR T cell and its application
|